A citation-based method for searching scientific literature

Masahide Takahashi. Proc Jpn Acad Ser B Phys Biol Sci 2022
Times Cited: 3







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Mutation analysis of the RET receptor tyrosine kinase in Hirschsprung disease.
M Angrist, S Bolk, B Thiel, E G Puffenberger, R M Hofstra, C H Buys, D T Cass, A Chakravarti. Hum Mol Genet 1995
206
66

Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cells.
Matti L Gild, Iñigo Landa, Mabel Ryder, Ronald A Ghossein, Jeffrey A Knauf, James A Fagin. Endocr Relat Cancer 2013
43
33


The RET kinase inhibitor NVP-AST487 blocks growth and calcitonin gene expression through distinct mechanisms in medullary thyroid cancer cells.
Nagako Akeno-Stuart, Michelle Croyle, Jeffrey A Knauf, Roberta Malaguarnera, Donata Vitagliano, Massimo Santoro, Christine Stephan, Konstantina Grosios, Markus Wartmann, Robert Cozens,[...]. Cancer Res 2007
92
33

Cancer-associated TERT promoter mutations abrogate telomerase silencing.
Kunitoshi Chiba, Joshua Z Johnson, Jacob M Vogan, Tina Wagner, John M Boyle, Dirk Hockemeyer. Elife 2015
173
33

Dl-3-n-Butylphthalide Reduces Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion Through GDNF/GFRα1/Ret Signaling Preventing Hippocampal Neuron Apoptosis.
Wenxian Li, Di Wei, Jiaxing Lin, Jianye Liang, Xiaomei Xie, Kangping Song, Li'an Huang. Front Cell Neurosci 2019
19
33

The major reverse transcriptase-incompetent splice variant of the human telomerase protein inhibits telomerase activity but protects from apoptosis.
Imke Listerman, Jie Sun, Francesca S Gazzaniga, Jason L Lukas, Elizabeth H Blackburn. Cancer Res 2013
112
33

Regulation of hTERT by BCR-ABL at multiple levels in K562 cells.
Juin Hsien Chai, Yong Zhang, Wei Han Tan, Wee Joo Chng, Baojie Li, Xueying Wang. BMC Cancer 2011
17
33

Separation of telomerase functions by reverse genetics.
Shibani Mukherjee, Eduardo J Firpo, Yang Wang, James M Roberts. Proc Natl Acad Sci U S A 2011
70
33

TERT-Regulation and Roles in Cancer Formation.
Marta Dratwa, Barbara Wysoczańska, Piotr Łacina, Tomasz Kubik, Katarzyna Bogunia-Kubik. Front Immunol 2020
33
33


Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer.
Robert J A Bell, H Tomas Rube, Alex Kreig, Andrew Mancini, Shaun D Fouse, Raman P Nagarajan, Serah Choi, Chibo Hong, Daniel He, Melike Pekmezci,[...]. Science 2015
346
33

Fundamental insights into the interaction between telomerase/TERT and intracellular signaling pathways.
Somayyeh Ghareghomi, Shahin Ahmadian, Nosratollah Zarghami, Houman Kahroba. Biochimie 2021
17
33

Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism.
Kunitoshi Chiba, Franziska K Lorbeer, A Hunter Shain, David T McSwiggen, Eva Schruf, Areum Oh, Jekwan Ryu, Xavier Darzacq, Boris C Bastian, Dirk Hockemeyer. Science 2017
154
33

AKT activation and telomerase reverse transcriptase expression are concurrently associated with prognosis of gastric cancer.
Takamitsu Sasaki, Hiroki Kuniyasu, Yi Luo, Misaho Kitayoshi, Eriko Tanabe, Daisuke Kato, Satoshi Shinya, Kiyomu Fujii, Hitoshi Ohmori, Yuichi Yamashita. Pathobiology 2014
27
33


Comprehensive analysis of kinase inhibitor selectivity.
Mindy I Davis, Jeremy P Hunt, Sanna Herrgard, Pietro Ciceri, Lisa M Wodicka, Gabriel Pallares, Michael Hocker, Daniel K Treiber, Patrick P Zarrinkar. Nat Biotechnol 2011
33

Antileukemic effects of the novel, mutant FLT3 inhibitor NVP-AST487: effects on PKC412-sensitive and -resistant FLT3-expressing cells.
Ellen Weisberg, Johannes Roesel, Guido Bold, Pascal Furet, Jingrui Jiang, Jan Cools, Renee D Wright, Erik Nelson, Rosemary Barrett, Arghya Ray,[...]. Blood 2008
26
33

Understanding TERT Promoter Mutations: A Common Path to Immortality.
Robert J A Bell, H Tomas Rube, Ana Xavier-Magalhães, Bruno M Costa, Andrew Mancini, Jun S Song, Joseph F Costello. Mol Cancer Res 2016
146
33

Mesenchymal and MAPK Expression Signatures Associate with Telomerase Promoter Mutations in Multiple Cancers.
Josh Lewis Stern, Grace Hibshman, Kevin Hu, Sarah E Ferrara, James C Costello, William Kim, Pablo Tamayo, Thomas R Cech, Franklin W Huang. Mol Cancer Res 2020
13
33

TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations.
Erik A Williams, Julie J Miller, Shilpa S Tummala, Tristan Penson, A John Iafrate, Tareq A Juratli, Daniel P Cahill. Acta Neuropathol Commun 2018
15
33

Involvement of the CDKL5-SOX9 signaling axis in rhabdomyolysis-associated acute kidney injury.
Ji Young Kim, Yuntao Bai, Laura A Jayne, Rachel E Cianciolo, Amandeep Bajwa, Navjot Singh Pabla. Am J Physiol Renal Physiol 2020
5
33


Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.
Ahmet Zehir, Ryma Benayed, Ronak H Shah, Aijazuddin Syed, Sumit Middha, Hyunjae R Kim, Preethi Srinivasan, Jianjiong Gao, Debyani Chakravarty, Sean M Devlin,[...]. Nat Med 2017
33

Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer.
Sumit Borah, Linghe Xi, Arthur J Zaug, Natasha M Powell, Garrett M Dancik, Scott B Cohen, James C Costello, Dan Theodorescu, Thomas R Cech. Science 2015
213
33

Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway.
Yoshiko Maida, Satoru Kyo, Taro Kanaya, Zhuo Wang, Noriyuki Yatabe, Masaaki Tanaka, Mitsuhiro Nakamura, Masahide Ohmichi, Noriko Gotoh, Seishi Murakami,[...]. Oncogene 2002
121
33

Targeting the RET pathway in thyroid cancer.
Samuel A Wells, Massimo Santoro. Clin Cancer Res 2009
124
33

Activation of mutant TERT promoter by RAS-ERK signaling is a key step in malignant progression of BRAF-mutant human melanomas.
Yinghui Li, Hui Shan Cheng, Wee Joo Chng, Vinay Tergaonkar. Proc Natl Acad Sci U S A 2016
62
33

Dynamic transcription factor activity profiling in 2D and 3D cell cultures.
Abigail D Bellis, Beatriz Peñalver Bernabé, Michael S Weiss, Seungjin Shin, Stanley Weng, Linda J Broadbelt, Lonnie D Shea. Biotechnol Bioeng 2013
18
33


Modulation of telomere protection by the PI3K/AKT pathway.
Marinela Méndez-Pertuz, Paula Martínez, Carmen Blanco-Aparicio, Elena Gómez-Casero, Ana Belen García, Jorge Martínez-Torrecuadrada, Marta Palafox, Javier Cortés, Violeta Serra, Joaquin Pastor,[...]. Nat Commun 2017
32
33

The multicellular tumor spheroid model for high-throughput cancer drug discovery.
Daniel V LaBarbera, Brian G Reid, Byong Hoon Yoo. Expert Opin Drug Discov 2012
159
33

Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers.
Josh Lewis Stern, Dan Theodorescu, Bert Vogelstein, Nickolas Papadopoulos, Thomas R Cech. Genes Dev 2015
131
33

TRIM28 is a transcriptional activator of the mutant TERT promoter in human bladder cancer.
Neeraj Agarwal, Sebastien Rinaldetti, Bassem B Cheikh, Qiong Zhou, Evan P Hass, Robert T Jones, Molishree Joshi, Daniel V LaBarbera, Simon R V Knott, Thomas R Cech,[...]. Proc Natl Acad Sci U S A 2021
8
33

TERT gene: its function and dysregulation in cancer.
Andrew J Colebatch, Alexander Dobrovic, Wendy A Cooper. J Clin Pathol 2019
31
33

TERT biology and function in cancer: beyond immortalisation.
Ana Pestana, João Vinagre, Manuel Sobrinho-Simões, Paula Soares. J Mol Endocrinol 2017
48
33

The RET proto-oncogene: a molecular therapeutic target in thyroid cancer.
Yoshinori Kodama, Naoya Asai, Kumi Kawai, Mayumi Jijiwa, Yoshiki Murakumo, Masatoshi Ichihara, Masahide Takahashi. Cancer Sci 2005
89
33

A survey of telomerase activity in human cancer.
J W Shay, S Bacchetti. Eur J Cancer 1997
33

Targeting the receptor tyrosine kinase RET in combination with aromatase inhibitors in ER positive breast cancer xenografts.
Elena Andreucci, Paola Francica, Antony Fearns, Lesley-Ann Martin, Paola Chiarugi, Clare M Isacke, Andrea Morandi. Oncotarget 2016
20
33

Interaction between a chromosome 10 RET enhancer and chromosome 21 in the Down syndrome-Hirschsprung disease association.
Stacey Arnold, Anna Pelet, Jeanne Amiel, Salud Borrego, Robert Hofstra, Paul Tam, Isabella Ceccherini, Stanislas Lyonnet, Stephanie Sherman, Aravinda Chakravarti. Hum Mutat 2009
43
33

Functional analysis of RET with Hirschsprung mutations affecting its kinase domain.
T Iwashita, K Kurokawa, S Qiao, H Murakami, N Asai, K Kawai, M Hashimoto, T Watanabe, M Ichihara, M Takahashi. Gastroenterology 2001
61
33

Association of Tumor Necrosis Factor-α (TNF-α) -308G>A and -238G>A Polymorphisms with Recurrent Pregnancy Loss Risk: A Meta-Analysis.
Fereshteh Aslebahar, Hossein Neamatzadeh, Bahare Meibodi, Mojgan Karimi-Zarchi, Razieh Sadat Tabatabaei, Mahmood Noori-Shadkam, Mahta Mazaheri, Reihaneh Dehghani-Mohammadabadi. Int J Fertil Steril 2019
8
33

Functional loss of semaphorin 3C and/or semaphorin 3D and their epistatic interaction with ret are critical to Hirschsprung disease liability.
Qian Jiang, Stacey Arnold, Tiffany Heanue, Krishna Praneeth Kilambi, Betty Doan, Ashish Kapoor, Albee Yun Ling, Maria X Sosa, Moltu Guy, Qingguang Jiang,[...]. Am J Hum Genet 2015
79
33

Genetic variants in RET, ARHGEF3 and CTNNAL1, and relevant interaction networks, contribute to the risk of Hirschsprung disease.
Yang Wang, Qian Jiang, Hao Cai, Ze Xu, Wenjie Wu, Beilin Gu, Long Li, Wei Cai. Aging (Albany NY) 2020
7
33

The developmental etiology and pathogenesis of Hirschsprung disease.
Naomi E Butler Tjaden, Paul A Trainor. Transl Res 2013
122
33

Is There Any Mosaicism in REarranged During Transfection Variant in Hirschsprung Disease's Patients?
Kristy Iskandar, Susan Simanjaya, Taufik Indrawan, Alvin Santoso Kalim, Marcellus, Didik Setyo Heriyanto, Gunadi. Front Pediatr 2022
1
100

Association between SULT1A1 Arg213His (rs9282861) Polymorphism and Risk of Breast Cancer: A Systematic Review and Meta-Analysis.
Mohammad Forat-Yazdi, Mohammadali Jafari, Saeed Kargar, Seyed Mojtaba Abolbaghaei, Rezvan Nasiri, Soudabeh Farahnak, Elnaz Foroughi, Hossein Neamatzadeh. J Res Health Sci 2017
7
33

A tutorial on sensitivity analyses in clinical trials: the what, why, when and how.
Lehana Thabane, Lawrence Mbuagbaw, Shiyuan Zhang, Zainab Samaan, Maura Marcucci, Chenglin Ye, Marroon Thabane, Lora Giangregorio, Brittany Dennis, Daisy Kosa,[...]. BMC Med Res Methodol 2013
345
33

Identifying candidate Hirschsprung disease-associated RET variants.
Grzegorz M Burzynski, Ilja M Nolte, Agnes Bronda, Krista K Bos, Jan Osinga, Ivan Plaza Menacho, Bas Twigt, Saskia Maas, Alice S Brooks, Joke B G M Verheij,[...]. Am J Hum Genet 2005
42
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.